CSE$NVO
Novo Nordisk B A/S · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Novo Nordisk Q4 2024: DKK 85.7B sales, DKK 28.2B net profit on 30% revenue growth
Novo Nordisk reported fourth quarter and full year 2024 results on February 5, 2025. Q4 net sales rose 30% to DKK 85,683 million with operating profit up 37% to DKK 36,737 million. Net profit for the quarter was DKK 28,230 million versus DKK 21,963 million in Q4 2023, and diluted EPS was DKK 6.34. Full year net sales grew 25% to DKK 290,403 million and full year net profit reached DKK 100,988 million with diluted EPS of DKK 22.63. Obesity care sales grew 56% in 2024 to DKK 65.1 billion. For 2025, management expects sales growth of 16–24% at constant exchange rates and operating profit growth of 19–27% at CER.
- Q4 net sales of DKK 85.7B up 30% YoY; operating profit up 37% to DKK 36.7B
- Q4 net profit of DKK 28.2B beat expectations; diluted EPS DKK 6.34
- Full year sales reached DKK 290.4B (+25%); obesity care sales DKK 65.1B (+56%)
- Completed acquisition of three Catalent manufacturing sites in December 2024
- 2025 outlook: 16–24% sales growth and 19–27% operating profit growth at CER
Headline financials
Revenue & EPS history
Novo Nordisk · Revenue · Quarterly
kr85.7B
Revenue by segment
Novo Nordisk · kr272B total across 1 segment · Q4 2024
- Diabetes and Obesity carekr272B—100.0%
Forward guidance
2025 sales growth expected at 16–24% CER and operating profit growth at 19–27% CER.
Tailwinds
- GLP-1 demand remains strong
- Pipeline progress on CagriSema and amycretin
Headwinds
- Guidance reflects intensifying competition and pricing pressure
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+31.7%
Avg return
Earnings day
+14.7%
Avg return
5 days after
+14.1%
Avg return
30 days after
50%
24 / 48 earnings
Positive
+597.3%
Q1 2025
Best reaction
-13.9%
Q2 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +556.0% | +569.8% | +533.1% | |
| Q3 2025 | -4.4% | -4.8% | -0.8% | |
| Q1 2025 | +597.3% | +3.0% | +9.0% | |
| Q4 2024 | +2.2% | +1.6% | +5.5% | |
| Q3 2024 | -0.2% | -0.9% | +0.6% | |
| Q2 2024 | -2.2% | -0.2% | +0.8% | |
| Q1 2024 | -3.9% | -1.5% | +4.7% | |
| Q3 2023 | +1.6% | +4.1% | +2.8% | |
| Q2 2023 | -2.9% | -1.3% | +4.2% | |
| Q1 2023 | -3.7% | +0.5% | -6.3% | |
| Q4 2022 | -5.1% | -0.5% | +4.4% | |
| Q3 2022 | +2.4% | +8.1% | +19.2% | |
| Q2 2022 | -9.1% | -10.5% | -10.7% | |
| Q1 2022 | +3.7% | +3.4% | -2.2% | |
| Q4 2021 | +4.9% | -0.8% | +1.5% | |
| Q3 2021 | +3.9% | +4.2% | -2.7% | |
| Q2 2021 | +0.3% | +1.9% | +2.7% | |
| Q1 2021 | +2.7% | +2.9% | +9.2% | |
| Q4 2020 | +1.1% | -0.1% | -1.9% | |
| Q3 2020 | -5.1% | +5.5% | +1.8% | |
| Q2 2020 | -3.3% | +0.2% | +0.0% | |
| Q1 2020 | -0.3% | +1.3% | +2.2% | |
| Q4 2019 | +4.4% | +3.3% | +1.6% | |
| Q3 2019 | +2.3% | +2.7% | +1.7% | |
| Q2 2019 | +3.9% | +3.2% | +3.7% | |
| Q1 2019 | -2.8% | -0.9% | -3.4% | |
| Q4 2018 | +2.7% | +3.5% | +5.5% | |
| Q3 2018 | +3.3% | -0.1% | +8.0% | |
| Q2 2018 | -5.4% | -5.8% | -4.5% | |
| Q1 2018 | +6.9% | +0.2% | +0.2% | |
| Q4 2017 | -9.1% | -10.8% | -8.6% | |
| Q3 2017 | -0.2% | -0.2% | +4.4% | |
| Q2 2017 | +0.0% | -2.1% | +2.6% | |
| Q1 2017 | +6.6% | +2.0% | +11.2% | |
| Q4 2016 | -8.4% | -9.0% | -5.5% | |
| Q3 2016 | -13.6% | -13.9% | -21.6% | |
| Q2 2016 | -13.9% | +0.6% | -20.1% | |
| Q1 2016 | -1.2% | +0.9% | -14.4% | |
| Q4 2015 | +5.0% | — | — | |
| Q3 2015 | -6.0% | — | — | |
| Q2 2015 | -4.5% | — | — | |
| Q1 2015 | +2.8% | — | — | |
| Q4 2014 | -2.8% | — | — | |
| Q3 2014 | +5.7% | — | — | |
| Q2 2014 | -3.5% | — | — | |
| Q1 2014 | +2.5% | — | — | |
| Q4 2013 | +9.5% | — | — | |
| Q3 2013 | +400.0% | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro